Possible treatment of hereditary-hormonal hair loss by particles isolated from stem cells in the laboratory
Phase 1
- Conditions
- androgenetic alopecia.Androgenic alopecia
- Registration Number
- IRCT20240508061704N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 5
Inclusion Criteria
Patients with male hereditary-hormonal hair loss
Patients with hair loss grade three to four Norwood-Hamilton classification
Exclusion Criteria
Patients receiving treatment for androgenetic alopecia during the last 3 months
Patients receiving systematic treatment of immunosuppressive or modulating drugs in the last 3 months
Patients receiving anticoagulants
Patients with a history of hair transplantation
Patients with a history of malignancy
Patients with a history of injection phobia
Patients with scalp infection or inflammation
Patients with serious and uncontrolled internal diseases such as diabetes and autoimmune diseases
Patients with unrealistic expectations of treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method